Brown adipose tissue activation with ginsenoside compound K ameliorates polycystic ovary syndrome

Abstract

In summary, CK treatment significantly activates BAT, increases CXCL14 expression and ameliorates PCOS. These findings suggest that CK might be a potential drug candidate for PCOS treatment.